scholarly article | Q13442814 |
P50 | author | Rebecca L Ashare | Q59859400 |
Caryn Lerman | Q66360703 | ||
Kosha Ruparel | Q80156402 | ||
Ruben C Gur | Q90481278 | ||
E Paul Wileyto | Q91919596 | ||
James W Loughead | Q114417307 | ||
Ryan D Hopson | Q114417310 | ||
P2093 | author name string | Jeffrey N Valdez | |
Patricia M Goelz | |||
P2860 | cites work | Association of COMT Val108/158Met genotype with smoking cessation | Q40134641 |
Some comments on frequently used multiple endpoint adjustment methods in clinical trials | Q41665319 | ||
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers | Q43140809 | ||
Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case-control study | Q43586657 | ||
Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism | Q44288862 | ||
Development of procedures for early screening of smoking cessation medications in humans | Q46664319 | ||
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. | Q48063516 | ||
Neuroimaging studies of practice-related change: fMRI and meta-analytic evidence of a domain-general control network for learning | Q48720301 | ||
The early time course of smoking withdrawal effects. | Q50935985 | ||
The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study. | Q52294114 | ||
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain | Q24534089 | ||
Stress signalling pathways that impair prefrontal cortex structure and function | Q24606025 | ||
Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism | Q28282922 | ||
Improved optimization for the robust and accurate linear registration and motion correction of brain images | Q29547542 | ||
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 | ||
Development and validation of brief measures of positive and negative affect: The PANAS scales | Q29614730 | ||
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia | Q29614929 | ||
Fast robust automated brain extraction | Q29615078 | ||
A global optimisation method for robust affine registration of brain images | Q29615079 | ||
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire | Q29615435 | ||
Varenicline improves mood and cognition during smoking abstinence | Q30483957 | ||
Practice induces function-specific changes in brain activity | Q30493215 | ||
Temporal autocorrelation in univariate linear modeling of FMRI data | Q30665534 | ||
Genes and the parsing of cognitive processes | Q30942053 | ||
Working memory deficits predict short-term smoking resumption following brief abstinence | Q33625059 | ||
COMT val108/158 met genotype affects neural but not cognitive processing in healthy individuals | Q33648088 | ||
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women | Q34092978 | ||
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction | Q34317550 | ||
Is there a common molecular pathway for addiction? | Q34463226 | ||
Tolcapone improves cognition and cortical information processing in normal human subjects | Q34576438 | ||
Effects of abstinence from tobacco: valid symptoms and time course | Q34577868 | ||
The effects of the COMT Val108/158Met polymorphism on BOLD activation during working memory, planning, and response inhibition: a role for the posterior cingulate cortex? | Q34662031 | ||
Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme | Q34721779 | ||
Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens | Q35583364 | ||
Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal | Q35779281 | ||
COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition | Q35859549 | ||
Lack of association between COMT and working memory in a population-based cohort of healthy young adults | Q36850559 | ||
Age-related differences in working memory deficits during nicotine withdrawal | Q36983140 | ||
Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype | Q37497959 | ||
Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings | Q39420790 | ||
Effect of nicotine on the tobacco withdrawal syndrome | Q39556613 | ||
P433 | issue | 3 | |
P304 | page(s) | 852-856 | |
P577 | publication date | 2013-09-14 | |
P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
P1476 | title | Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study | |
P478 | volume | 133 |
Q37195931 | A reverse factual analysis of the association between smoking and memory decline in China |
Q28074860 | COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review |
Q26744718 | Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies |
Q41996915 | The Role of Working Memory for Cognitive Control in Anorexia Nervosa versus Substance Use Disorder |
Q35421004 | Working memory-related neural activity predicts future smoking relapse |
Search more.